JPS6043349B2 - 1,2-diazepine compound with fused heterocycle - Google Patents
1,2-diazepine compound with fused heterocycleInfo
- Publication number
- JPS6043349B2 JPS6043349B2 JP52106816A JP10681677A JPS6043349B2 JP S6043349 B2 JPS6043349 B2 JP S6043349B2 JP 52106816 A JP52106816 A JP 52106816A JP 10681677 A JP10681677 A JP 10681677A JP S6043349 B2 JPS6043349 B2 JP S6043349B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- diazepine
- compound
- light
- fused heterocycle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Description
【発明の詳細な説明】
本発明は一般式(I)で示される新規なヘテロ環の縮合
した1・2−ジアゼピン誘導体、およびその製造方法に
関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel heterocyclic fused 1,2-diazepine derivative represented by general formula (I) and a method for producing the same.
(I)
式中、Aは縮合したピリジン、チオフェン、またはフラ
ンン環を示す。(I) In the formula, A represents a fused pyridine, thiophene, or furan ring.
本発明の式(I)で示される化合物は新規な化合物であ
り、中枢神経抑制作用を有し、医薬品まヨたはその中間
体として有用な化合物である。The compound represented by formula (I) of the present invention is a novel compound, has a central nervous system depressing effect, and is a compound useful as a pharmaceutical or an intermediate thereof.
本発明の化合物(I)は、式(■)で示されるヘテロ環
の縮合したピリジン誘導体を0−アミノスルホン酸誘導
体などの適当なN−アミノ化剤でアミノ化し、式(■)
で示されるヘテロ環の縮合・したN−アミノピリジン誘
導体を製造し、次いでこれをアルカリと反応させ、式(
■)で示されるイリド誘導体を製造し、次いでこれを適
当な溶媒中で光照射することにより製造することができ
る。これを反応式で示せば下記のとおりである。式中、
Aは縮合したピリジン、チオフェンまたはフラン環を示
す。本発明の化合物を製造するに当つては上記原料化合
物(m)を有機溶媒に溶解し、ほぼ当モル量のO−アミ
ノスルホン酸誘導体などのN−アミノ化剤を反応させる
とほぼ純粋なN−アミノピリジン誘導体のスルホン酸塩
(■)が90〜95%の収率で得られる。Compound (I) of the present invention can be obtained by aminating a pyridine derivative having a condensed heterocycle represented by formula (■) with a suitable N-aminating agent such as an 0-aminosulfonic acid derivative,
A fused N-aminopyridine derivative of the heterocycle represented by the formula is prepared, and then this is reacted with an alkali to form the formula (
It can be produced by producing the ylide derivative represented by (2) and then irradiating it with light in an appropriate solvent. This reaction formula is shown below. During the ceremony,
A represents a fused pyridine, thiophene or furan ring. In producing the compound of the present invention, the above raw material compound (m) is dissolved in an organic solvent and reacted with an approximately equimolar amount of an N-aminating agent such as an O-aminosulfonic acid derivative. - The sulfonate salt (■) of an aminopyridine derivative is obtained in a yield of 90-95%.
この塩を水に溶かし、水酸化ナトリウム、炭酸カリウム
などでアルカリ性にすると結晶が析出する。これを沖取
し水洗するとほぼ純粋な二量体(■−b)が得られる。
この二量体は溶液中では式(■−a)で示されるイリド
誘導体と平衡状態にある。When this salt is dissolved in water and made alkaline with sodium hydroxide, potassium carbonate, etc., crystals will precipitate. When this is removed and washed with water, an almost pure dimer (■-b) is obtained.
This dimer is in equilibrium with the ylide derivative represented by formula (■-a) in solution.
この二量体を適当な溶媒中でかくはんしながら高圧水銀
灯で光照射し常法に従つて処理すると目的とするヘテロ
環の縮合した1・2−ジアゼピン誘導体(1)が得られ
る。光照射の際に用いられる溶媒は、原料二量体を溶解
させるいかなる溶媒をも用いうるが、塩化メチレン、ア
セトンが望ましく、特にこれらに氷酢酸を2〜3%加え
たものが最も望ましい。二量体を生成し難いものについ
てはスルホン酸塩(■)をメタノールに溶かし、光照射
をしながら2倍モル量の水酸化ナトリウムのメタノール
溶液を徐々に加えるとジアゼピンが得られる。光源は通
常用いられる高圧水銀灯で良く、その強さは、その時使
用される原料物質の量により適当に選択される。反応終
了後、目的化合物は常法に従つて反応混合物から採取さ
れる。This dimer is stirred in a suitable solvent, irradiated with light using a high-pressure mercury lamp, and treated according to a conventional method to obtain the desired 1,2-diazepine derivative (1) with a condensed heterocycle. The solvent used during the light irradiation may be any solvent capable of dissolving the raw material dimer, but methylene chloride and acetone are preferred, and the most preferred are those to which 2 to 3% of glacial acetic acid is added. For substances that are difficult to form dimers, diazepine can be obtained by dissolving the sulfonate (■) in methanol and gradually adding a methanol solution of twice the molar amount of sodium hydroxide while irradiating with light. The light source may be a commonly used high-pressure mercury lamp, the intensity of which is appropriately selected depending on the amount of raw material used at the time. After the reaction is completed, the target compound is collected from the reaction mixture according to a conventional method.
例えば、酢酸含有塩化メチレンを溶媒として用いた楊合
、反応終了後反応液を炭酸水素ナトリウム飽和溶液など
の弱いアルカリ水溶液で酢酸を抽出除去し、水洗したの
ち無水硫酸ナトリウムなどの乾燥剤で乾燥する。この溶
液から溶剤の塩化メチレンを留去することにより目的化
合物を得ることができる。得られた目的化合物は、更に
必要に応じて再結晶、カラムクロマトグラフィーなどに
対することにより純品として得ることができる。次に実
施例をあげて、本発明をさらに具体的に説明する。For example, by using acetic acid-containing methylene chloride as a solvent, after the reaction is completed, acetic acid is extracted from the reaction solution with a weak alkaline aqueous solution such as a saturated sodium bicarbonate solution, washed with water, and then dried with a desiccant such as anhydrous sodium sulfate. . The target compound can be obtained by distilling off the solvent methylene chloride from this solution. The obtained target compound can be further subjected to recrystallization, column chromatography, etc. as necessary to obtain a pure product. Next, the present invention will be explained in more detail with reference to Examples.
実施例1
ピリド〔2・3−C〕−1H−1・2−ジアゼピン1・
8−ナフチリジンから一般的製法に従つて合成した二量
体(2y)を2%氷酢酸含有塩化メチレン(300m1
)に溶かし、攪拌しながら400W高圧水銀灯を用いて
内部照射法により5時間光照射する。Example 1 Pyrido[2.3-C]-1H-1.2-diazepine 1.
The dimer (2y) synthesized from 8-naphthyridine according to a general method was added to methylene chloride containing 2% glacial acetic acid (300ml).
) and irradiated with light for 5 hours by internal irradiation method using a 400W high-pressure mercury lamp while stirring.
反応液を重曹水で洗つて氷酢酸を除き、水洗、乾燥後溶
媒を留去して得られた残留物をアルミナカラムクロマト
グラフィーに付し、塩化メチレン溶出液から目的化合物
が純品として、450m9得られた。M.p.ll3〜
114物、赤色プリズム晶(イソプロピルエ−テルーベ
ンゼン混液から)K.K♀Hnm(ε):234(19
000)、313(2000)、MSm/e:145(
Mつν?■礪−1:3250(NH)
δ(CDCl3):5.84(1H..dd)、6.5
8(1H..d)、6.87(1HNd)、7.02(
1H,,d)、7.24(1H1d)、8.09(1H
..d)、7.3(1H..br).元素分析値C8H
7N3計算値:Cl66.l9;Hl4.86:Nl2
8.95実測値:Cl66.O6;Hl4.8l;Nl
28.93実施例2ピリド〔3・2−C〕−1H−1・
2−ジアゼピン1・5−ナフチリジンから一般的製法に
従つて合成した二量体(1.5q)を2%氷酢酸含有塩
化メチレン(300mL)中で、実施例1と同様な条件
で光照射し、処理し、目的化合物360mgを得た。The reaction solution was washed with aqueous sodium bicarbonate to remove glacial acetic acid, washed with water, dried, and then the solvent was distilled off. The resulting residue was subjected to alumina column chromatography, and the target compound was purified as a pure product from the methylene chloride eluate. Obtained. M. p. ll3~
114, red prismatic crystals (from isopropyl ether-benzene mixture) K. K♀Hnm (ε): 234 (19
000), 313 (2000), MSm/e:145(
M Tsunu? ■礪-1: 3250 (NH) δ (CDCl3): 5.84 (1H..dd), 6.5
8 (1H..d), 6.87 (1HNd), 7.02 (
1H,,d), 7.24 (1H1d), 8.09 (1H
.. .. d), 7.3 (1H..br). Elemental analysis value C8H
7N3 calculated value: Cl66. l9; Hl4.86: Nl2
8.95 Actual value: Cl66. O6; Hl4.8l; Nl
28.93 Example 2 Pyrido[3.2-C]-1H-1.
A dimer (1.5 q) synthesized from 2-diazepine 1,5-naphthyridine according to a general method was irradiated with light in methylene chloride (300 mL) containing 2% glacial acetic acid under the same conditions as in Example 1. , to obtain 360 mg of the target compound.
M.p.ll9〜120的、赤色針状晶(イソプロピル
エ−テルーベンゼン混液から)λ=Ta,。M. p. 119-120, red needle crystals (from isopropyl ether-benzene mixture) λ=Ta,.
)Hnm(ε):232(16000)、306(30
00)、NSm/e:145(Mつν琵■礪−1:32
00(NH)
δ(CDCl3):6.18(1H.dd)、7.02
(1H,.d)、7.16(1H..d)、6.8〜7
.3(2H,.m)、8.26(1H..d)、6.6
(1H..br)元素分析値C8H7N3
計算値:Cl66.l9;Hl4.86;Nl28.9
5実測値:Cl66.l8;Hl4.88;Nl28.
9O実施例3チエノ〔2・3−C〕−1H−1・2−ジ
アゼピンチエノ〔2・3−b〕ピリジンから一般的製法
に従つて合成したメシチレンスルフオン酸塩(これから
二量体が得られ難い)3.5yを350mLのメタノー
ルに溶かし光照射しながら水酸化ナトリウム(1.3y
)のメタノール(5m1)溶液を2紛間を要して滴下す
る。) Hnm (ε): 232 (16000), 306 (30
00), NSm/e: 145 (Mtsuν琵■礪-1:32
00(NH) δ(CDCl3): 6.18(1H.dd), 7.02
(1H,.d), 7.16 (1H..d), 6.8-7
.. 3 (2H,.m), 8.26 (1H..d), 6.6
(1H..br) Elemental analysis value C8H7N3 Calculated value: Cl66. l9; Hl4.86; Nl28.9
5 Actual value: Cl66. l8; Hl4.88; Nl28.
9O Example 3 Thieno[2,3-C]-1H-1,2-diazepine Mesitylene sulfonate synthesized from thieno[2,3-b]pyridine according to a general method (from which a dimer can be obtained) Dissolve 3.5y (difficult) in 350mL of methanol and add sodium hydroxide (1.3y
) was added dropwise in two drops in methanol (5 ml).
さらに1.5時間光照射したのち、溶媒を留去して得ら
れた残留物をエーテルで抽出し、抽出液からエーテルを
留去した残留物をアルミナカラムクロマトグラフィーに
付し、エ−テルーn−ヘキサン混液溶出液から目的化合
物1.1ダを得た。M.p.8l〜83溶、赤色針状晶
(イソプロピルエーテルから)λ??Hnm(ε):2
50(11000)、MSm/El5O(Mつν瓢■C
m−1:3200(NH)
δ(CDCl3):5.98(1H..dd)、6.6
7(1H..d)、6.75(1H..d)、6.8(
1H..br)、6.81(1H1d)、6.94(1
H.sd).元素分析値C7H6N2S
計算値:Cl55.98;Hl4.O3;Nll8.6
5実測値:Cl56.Ol;Hl4.O2;Nll8.
58実施例4チエノ〔3・2−c〕−1H−1・2−ジ
アゼピンチエノ〔3・2−b〕ピリジンから得られるメ
シチレンスルフオン酸塩(3.5y)を実施例3と同様
な方法で光照射したのち、同様に処理して、目的化合物
950mgを得た。After further irradiation with light for 1.5 hours, the solvent was distilled off and the resulting residue was extracted with ether.The ether was distilled off from the extract, and the residue was subjected to alumina column chromatography. -1.1 da of the target compound was obtained from the hexane mixture eluate. M. p. 8l~83 solution, red needle crystals (from isopropyl ether) λ? ? Hnm(ε): 2
50 (11000), MSm/El5O (M ν Gourd ■C
m-1: 3200 (NH) δ (CDCl3): 5.98 (1H..dd), 6.6
7 (1H..d), 6.75 (1H..d), 6.8 (
1H. .. br), 6.81 (1H1d), 6.94 (1
H. sd). Elemental analysis value C7H6N2S Calculated value: Cl55.98; Hl4. O3;Nll8.6
5 Actual value: Cl56. Ol; Hl4. O2;Nll8.
58 Example 4 Thieno[3,2-c]-1H-1,2-diazepine Mesitylene sulfonate (3.5y) obtained from thieno[3,2-b]pyridine was prepared in the same manner as in Example 3. After irradiation with light, the same treatment was performed to obtain 950 mg of the target compound.
M.p.94〜95g、赤色針状晶(イソプロピルエー
テルから)λ二?Hnrrl.(ε):277(100
00)、NSm/e:150(Mつν瓢Nc!n−1:
3250(NH)
δ(CDCl3):5.92(1H..dd)、6.4
2(1H,.d)、6.6(1H..br)、6.68
(1H,.d)、6.83(1H1d)、7.28(1
H..d)元素分析値C7H6N2S
計算値:Cl55.98;Hl4.O3;Nl8.65
実測値:Cl55.9l;Hl4.OO;Nll8.6
2実施例5フロ〔2・3−c〕−1H−1・2−ジアゼ
ピンフロ〔2・3−b〕ピリジンから得られるメシチレ
ンスルフオン酸塩(3.34y)を実施例3と同様な条
件で光照射し、同様に処理して目的化合物約600m9
を得た。M. p. 94-95 g, red needles (from isopropyl ether) λ2? Hnrrl. (ε):277(100
00), NSm/e: 150 (M ν Gourd Nc!n-1:
3250 (NH) δ (CDCl3): 5.92 (1H..dd), 6.4
2 (1H,.d), 6.6 (1H..br), 6.68
(1H,.d), 6.83 (1H1d), 7.28 (1
H. .. d) Elemental analysis value C7H6N2S Calculated value: Cl55.98; Hl4. O3;Nl8.65
Actual value: Cl55.9l; Hl4. OO;Nll8.6
2 Example 5 Mesitylene sulfonate (3.34y) obtained from Furo[2,3-c]-1H-1,2-diazepine Furo[2,3-b]pyridine was treated under the same conditions as in Example 3. Approximately 600 m9 of the target compound was irradiated with light and treated in the same manner.
I got it.
赤色粘稠な液体で不安定
λ二?Hnwl,(ε):255.MSm/e:134
(Mつν♀?o−1:3250(NH)δ(CJ)6)
:5.28(1H..dd)、5.70(1H,.d)
、5.99(1H..d)、6.4(1H..br)、
6.46(2H1m)元素分析値C7H6N2ORed viscous liquid and unstable λ2? Hnwl, (ε): 255. MSm/e:134
(M ν♀?o-1:3250(NH)δ(CJ)6)
:5.28 (1H..dd), 5.70 (1H,.d)
, 5.99 (1H..d), 6.4 (1H..br),
6.46 (2H1m) Elemental analysis value C7H6N2O
Claims (1)
は縮合したピリジン、チオフェンまたはフラン環を示す
)で示されるヘテロ環の縮合した1・2−ジアゼピン誘
導体。 2 一般式(II) ▲数式、化学式、表等があります▼ (II) (式中、Aは縮合したピリジン、チオフェンまたはフラ
ン環を示す)で示されるヘテロ環の縮合したN−イミノ
ピリジン誘導体を光照射することを特徴とする一般式(
I )▲数式、化学式、表等があります▼( I )(式中
、Aは上記のとおりである) で示されるヘテロ環の縮合した1・2−ジアゼピン誘導
体の製造方法。[Claims] 1 General formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) (In the formula, A
is a fused pyridine, thiophene or furan ring). 2 General formula (II) ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (II) (In the formula, A represents a fused pyridine, thiophene or furan ring) A general formula characterized by light irradiation (
I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) (In the formula, A is as above) A method for producing a 1,2-diazepine derivative with a condensed heterocycle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP52106816A JPS6043349B2 (en) | 1977-09-07 | 1977-09-07 | 1,2-diazepine compound with fused heterocycle |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP52106816A JPS6043349B2 (en) | 1977-09-07 | 1977-09-07 | 1,2-diazepine compound with fused heterocycle |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5441887A JPS5441887A (en) | 1979-04-03 |
| JPS6043349B2 true JPS6043349B2 (en) | 1985-09-27 |
Family
ID=14443338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52106816A Expired JPS6043349B2 (en) | 1977-09-07 | 1977-09-07 | 1,2-diazepine compound with fused heterocycle |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6043349B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0143424B1 (en) * | 1983-11-25 | 1990-06-27 | Fuji Photo Film Co., Ltd. | Heat-developable light-sensitive materials |
-
1977
- 1977-09-07 JP JP52106816A patent/JPS6043349B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5441887A (en) | 1979-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7266538B2 (en) | Lactam compounds as FXR receptor agonists | |
| SU776557A3 (en) | Method of preparing optically active anthracyclinones | |
| JPH0737460B2 (en) | Pyranoindolizine derivative and method for producing the same | |
| PL164955B1 (en) | Method of obtaining novel indolone derivatives | |
| US4232157A (en) | Process for preparing lysergol derivatives | |
| KR20050061490A (en) | Process and intermediates for the preparation of thienopyrrole derivatives | |
| CA2898274A1 (en) | Method for producing tricyclic compound, and tricyclic compound capable of being produced by said production method | |
| Zhao et al. | Metal-and additive-free cascade trifluoroethylation/cyclization of organic isoselenocyanates by phenyl (2, 2, 2-trifluoroethyl) iodonium triflate | |
| JPS6043349B2 (en) | 1,2-diazepine compound with fused heterocycle | |
| EP2799426B1 (en) | New process for the synthesis of aminaphtone | |
| JP7575764B2 (en) | Dipyrromethene-1-one compounds and their production method | |
| US20040110944A1 (en) | 4,7-Disubstituted indoles and methods of making | |
| JP3338854B2 (en) | Method for producing new areno [e] indole | |
| Benn et al. | Attempts at the Synthesis of the Penicillin Ring System by Transannular Reactions | |
| HU186974B (en) | Process for the preparation of 3a,7a-trans-4-bracket-7,7-ethylendioxy-3-oxo-octyl-bracket closed-7abeta-methyl-perhydro-indan-1,5-dione | |
| Arai et al. | 6-Demethyl-6-halo-and 6-demethyl-6-thiomitomycins: synthesis of novel mitomycin derivatives involving a tandem Michael addition/retro-Mannich reaction sequence | |
| JPS59116285A (en) | 15-halo-e-homoeburnane derivative and manufacture | |
| CN110845445A (en) | Connecting body, preparation method and application thereof, and thalidomide-based PROTACs intermediate and application thereof | |
| JPS6053039B2 (en) | N-Acetyl/Iramic acid derivative and method for producing the same | |
| AU2004326111A1 (en) | Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI | |
| CN113549085B (en) | A kind of synthetic method of natural product 6-HHC | |
| Lal et al. | A novel entry into 1, 2, 3, 4, 5, 6-hexahydro-3-benzazocine-4, 6-dione and 2-substituted-2, 5, 6, 7-tetrahydro-4-benzazonine-1, 3-(4H)-dione | |
| JPS6213953B2 (en) | ||
| JP2000355591A (en) | Production of indole derivative and its intermediate | |
| KR820001238B1 (en) | Process for preparing lysergol derivatives |